Enveric Biosciences Announces Participation in 2026 BIO International Convention

Enveric Biosciences, a biotech firm focusing on novel therapies for mental and neurological conditions, is set to showcase its advancements at the 2026 BIO International Convention in San Diego. This participation underscores the company's growing influence in the biotechnology sector and its commitment to innovative treatments. The convention provides a platform for networking and showcasing potential breakthroughs, highlighting the importance of such events in fostering industry collaboration and progress in medical research.